![](/img/cover-not-exists.png)
[Lupus Foundation of America 13th International Congress on Systemic Lupus Erythematosus (LUPUS 2019), San Francisco, California, USA, April 5â8, 2019, Abstract Presentations - ()] Abstracts - 178â Phase 2 trial of induction therapy with anti-CD20 (Rituximab) followed by maintenance therapy with anti-BAFF (Belimumab) in patients with active lupus nephritis
Aranow, Cynthia, DallEra, Maria C, Byron, Margaret, Ding, Linna, Smilek, Dawn, Diamond, Betty, Wofsy, DavidYear:
2019
DOI:
10.1136/lupus-2019-lsm.178
File:
PDF, 155 KB
2019